Estrella Immunopharma, Inc. (ESLA)
ESLA Stock Price Chart
Explore Estrella Immunopharma, Inc. interactive price chart. Choose custom timeframes to analyze ESLA price movements and trends.
ESLA Company Profile
Discover essential business fundamentals and corporate details for Estrella Immunopharma, Inc. (ESLA) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Biotechnology
IPO Date
14 Sept 2021
Employees
3.00
Website
https://www.estrellabio.comCEO
Cheng Liu
Description
Estrella Immunopharma, Inc. is an early-stage biopharmaceutical enterprise focused on creating T-cell therapies for various blood cancers and solid tumors, with its primary activities centered in the United States. The company's lead investigational drugs include EB103, which is in preclinical development for diffuse large B-cell lymphoma, and EB104, intended for the treatment of both diffuse large B-cell lymphoma and acute lymphocytic leukemia. Estrella also maintains a collaborative agreement with Imugene Limited, working together to develop solid tumor therapies that integrate Imugene's CF33-CD19t product candidate with Estrella's EB103. The company is based in Emeryville, California.
ESLA Financial Timeline
Browse a chronological timeline of Estrella Immunopharma, Inc. corporate events including earnings releases, dividend announcements, and stock splits.
Upcoming earnings on 2 Sept 2026
EPS estimate is -$0.09.
Earnings released on 15 May 2026
EPS came in at -$0.05 surpassing the estimated -$0.08 by +40.48%.
Earnings released on 18 Mar 2026
EPS came in at -$0.02 surpassing the estimated -$0.18 by +91.00%.
Earnings released on 12 Nov 2025
EPS came in at -$0.13 surpassing the estimated -$0.19 by +30.29%.
Earnings released on 11 Aug 2025
EPS came in at -$0.15 falling short of the estimated -$0.07 by -114.29%.
Earnings released on 14 May 2025
EPS came in at -$0.06 surpassing the estimated -$0.11 by +45.45%.
Earnings released on 15 Feb 2025
EPS came in at -$0.12 matching the estimated -$0.12.
Earnings released on 14 Nov 2024
EPS came in at -$0.09 .
Earnings released on 27 Sept 2024
EPS came in at -$0.13 .
Earnings released on 14 May 2024
EPS came in at -$0.01 .
Earnings released on 14 Feb 2024
EPS came in at -$0.03 .
ESLA Stock Performance
Access detailed ESLA performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.
